The latest update is out from OptimizeRx (OPRX).
At OptimizeRx Corporation’s 2024 Annual Meeting, stockholders have given their nod to several key proposals, including the expansion of the company’s Equity Incentive Plan by an additional 1,950,000 shares. This strategic amendment aims to incentivize performance and attract talent by increasing the total available shares for awards to 4,450,000. The meeting also saw the election of six directors and the approval of executive compensation on an advisory basis. Additionally, UHY LLP has been reappointed as the independent auditor for the fiscal year 2024, reinforcing stockholders’ confidence in the company’s financial oversight.
See more data about OPRX stock on TipRanks’ Stock Analysis page.
